BMRN vs. JAZZ
BMRN (BioMarin Pharmaceutical Inc.) and JAZZ (Jazz Pharmaceuticals plc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, BMRN returned -4.89%/yr vs 5.67%/yr for JAZZ. Their 0.37 correlation means their historical movements had little consistent relationship.
Performance
BMRN vs. JAZZ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BMRN achieves a 0.81% return, which is significantly lower than JAZZ's 53.86% return. Over the past 10 years, BMRN has underperformed JAZZ with an annualized return of -4.89%, while JAZZ has yielded a comparatively higher 5.67% annualized return.
BMRN
- 1D
- -1.33%
- 1M
- 1.91%
- 6M
- 3.97%
- YTD
- 0.81%
- 1Y
- -3.26%
- 3Y*
- -12.21%
- 5Y*
- -5.17%
- 10Y*
- -4.89%
- ALL TIME*
- 5.72%
JAZZ
- 1D
- -0.02%
- 1M
- 7.13%
- 6M
- 57.84%
- YTD
- 53.86%
- 1Y
- 131.07%
- 3Y*
- 26.20%
- 5Y*
- 11.76%
- 10Y*
- 5.67%
- ALL TIME*
- 15.14%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $109.56M | $94.79M | $114.29M | |
| $225.74M | $196.10M | $205.87M |
BMRN vs. JAZZ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BMRN BioMarin Pharmaceutical Inc. | 0.81% | -9.58% | -31.83% | -6.83% | 17.14% | 0.75% | 3.71% | -0.70% | -4.51% | 7.64% |
JAZZ Jazz Pharmaceuticals plc | 53.86% | 38.04% | 0.12% | -22.79% | 25.05% | -22.81% | 10.56% | 20.43% | -7.94% | 23.50% |
Correlation
The correlation between BMRN and JAZZ is 0.34, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.34 |
Correlation (3Y) Balances recent behavior with more history. | 0.31 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.36 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.37 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2007 | 0.37 |
Fundamentals
BMRN:
$11.58B
JAZZ:
$16.43B
BMRN:
$1.37
JAZZ:
$14.58
BMRN:
43.63
JAZZ:
17.94
BMRN:
2.61
JAZZ:
1.17
BMRN:
3.62
JAZZ:
3.67
BMRN:
1.91
JAZZ:
3.78
BMRN:
$3.24B
JAZZ:
$4.60B
BMRN:
$2.46B
JAZZ:
$2.80B
BMRN:
$439.56M
JAZZ:
$1.31B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BMRN vs. JAZZ — Risk / Return Rank
BMRN
JAZZ
BMRN vs. JAZZ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BioMarin Pharmaceutical Inc. (BMRN) and Jazz Pharmaceuticals plc (JAZZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BMRN | JAZZ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.62 | ||
| Sortino ratioReturn per unit of downside risk | -4.95 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.65 | -0.63 |
| Calmar ratioReturn relative to maximum drawdown | -0.15 | 11.55 | -11.70 |
| Martin ratioReturn relative to average drawdown | -0.30 | 29.14 | -29.44 |
Loading charts...
Drawdowns
BMRN vs. JAZZ - Drawdown Comparison
The maximum BMRN drawdown since its inception was -90.58%, smaller than the maximum JAZZ drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for BMRN and JAZZ.
Loading charts...
Drawdown Indicators
| BMRN | JAZZ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.58% | -96.90% | +6.32% |
Max Drawdown (1Y)Largest decline over 1 year | -22.49% | -11.42% | -11.07% |
Max Drawdown (3Y)Largest decline over 3 years | -49.83% | -32.71% | -17.12% |
Max Drawdown (5Y)Largest decline over 5 years | -57.64% | -42.03% | -15.61% |
Max Drawdown (10Y)Largest decline over 10 years | -62.09% | -52.10% | -9.99% |
Current DrawdownCurrent decline from peak | -59.83% | -0.02% | -59.81% |
Average DrawdownAverage peak-to-trough decline | -45.60% | -27.19% | -18.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.45% | 4.54% | +6.91% |
Volatility
BMRN vs. JAZZ - Volatility Comparison
The current volatility for BioMarin Pharmaceutical Inc. (BMRN) is 5.61%, while Jazz Pharmaceuticals plc (JAZZ) has a volatility of 8.21%. This indicates that BMRN experiences smaller price fluctuations and is considered to be less risky than JAZZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BMRN | JAZZ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.61% | 8.21% | -2.60% |
Volatility (6M)Calculated over the trailing 6-month period | 22.06% | 23.12% | -1.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.23% | 37.57% | -3.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.93% | 31.63% | +1.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.03% | 32.73% | +2.30% |
Dividends
BMRN vs. JAZZ - Dividend Comparison
Neither BMRN nor JAZZ has paid dividends to shareholders.
Financials
BMRN vs. JAZZ - Financials Comparison
This section allows you to compare key financial metrics between BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BMRN vs. JAZZ - Profitability Comparison
BMRN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, BioMarin Pharmaceutical Inc. reported a gross profit of 571.21M and revenue of 766.21M. Therefore, the gross margin over that period was 74.6%.
JAZZ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Jazz Pharmaceuticals plc reported a gross profit of 0.00 and revenue of 1.21B. Therefore, the gross margin over that period was 0.0%.
BMRN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, BioMarin Pharmaceutical Inc. reported an operating income of 129.64M and revenue of 766.21M, resulting in an operating margin of 16.9%.
JAZZ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Jazz Pharmaceuticals plc reported an operating income of 248.20M and revenue of 1.21B, resulting in an operating margin of 20.5%.
BMRN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, BioMarin Pharmaceutical Inc. reported a net income of 105.53M and revenue of 766.21M, resulting in a net margin of 13.8%.
JAZZ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Jazz Pharmaceuticals plc reported a net income of 192.80M and revenue of 1.21B, resulting in a net margin of 16.0%.
Frequently Asked Questions
BMRN and JAZZ have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JAZZ has higher volatility (8.21%) compared to BMRN (5.61%). In terms of maximum drawdown, BMRN dropped -90.58% vs JAZZ's -96.90%.
JAZZ currently has the higher Sharpe Ratio (3.52 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BMRN and JAZZ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer